PubRank

An Open Label Study of CM-AT for the Treatment of Children With Autism

Clinical Trial ID NCT02649959

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02649959

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Global prevalence of autism and other pervasive developmental disorders. Autism Res 2012 4.62
2 The lifetime distribution of the incremental societal costs of autism. Arch Pediatr Adolesc Med 2007 3.50
3 A systematic review of medical treatments for children with autism spectrum disorders. Pediatrics 2011 2.94
4 A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. J Am Acad Child Adolesc Psychiatry 2009 2.69
5 Co-occurring conditions associated with FMR1 gene variations: findings from a national parent survey. Am J Med Genet A 2008 2.50
6 Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics 2010 2.45
7 Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits. Neuron 2014 2.44
8 A comparison of eating behaviors between children with and without autism. J Autism Dev Disord 2004 1.67
9 Food preferences and factors influencing food selectivity for children with autism spectrum disorders. Res Dev Disabil 2005 1.35
10 Gastrointestinal symptoms in autism spectrum disorder: a meta-analysis. Pediatrics 2014 1.33
11 Asparagine synthetase: regulation by cell stress and involvement in tumor biology. Am J Physiol Endocrinol Metab 2013 1.26
12 Plasma amino acids profiles in children with autism: potential risk of nutritional deficiencies. J Autism Dev Disord 2003 1.25
13 Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). Cochrane Database Syst Rev 2010 1.23
14 Attention deficit/hyperactivity disorder symptoms moderate cognition and behavior in children with autism spectrum disorders. Autism Res 2009 1.17
15 Autism spectrum disorders and health care expenditures: the effects of co-occurring conditions. J Dev Behav Pediatr 2012 1.14
16 Pancreatic enzymes generate cytotoxic mediators in the intestine. Shock 2007 1.07
17 Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism. Mol Psychiatry 2004 1.02
18 An evaluation of the Gilliam Autism Rating Scale. J Autism Dev Disord 2005 0.92
19 The fecal chymotrypsin photometric assay in the evaluation of exocrine pancreatic capacity. Comparison with other direct and indirect pancreatic function tests. Pancreas 1989 0.92
20 Update on the evaluation of pancreatic exocrine status in cystic fibrosis. Curr Opin Pulm Med 2005 0.88
21 Comparison of preservation media for storage of stool samples. J Clin Microbiol 1995 0.88
22 Comparison of the absorption of two protein hydrolysates and their effects on water and electrolyte movements in the human jejunum. Gut 1980 0.88
23 Digestive enzyme supplementation for autism spectrum disorders: a double-blind randomized controlled trial. J Autism Dev Disord 2010 0.85
24 Autistic children exhibit distinct plasma amino acid profile. Indian J Biochem Biophys 2013 0.81
25 Intestinal absorption of amino acids and peptides. Proc Nutr Soc 1972 0.80
26 Pathophysiology of autism spectrum disorders: revisiting gastrointestinal involvement and immune imbalance. World J Gastroenterol 2014 0.79
Next 100